跳至主要内容
临床试验/NCT06031090
NCT06031090招募中2 期

Intravenous Clonidine Versus Granisetron for Prevention of Post Spinal Anesthesia Shivering in Cesarean Section

Zagazig University1 个研究点 分布在 1 个国家目标入组 186 人开始时间: 2023年3月5日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
186
试验地点
1
主要终点
Incidence of Shivering

研究概览

简要总结

Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption

详细描述

Shivering is one of the most important periperative complications seen in clinical practice. Several mechanisms have been postulated for its pathogenesis. Anesthetic-induced inhibition of thermoregulation resulting in hypothermia is an important cause of post anesthesia shivering, uncontrolled spinal reflexes, and cutaneous vasodilation are the other suggested mechanisms involved in the pathogenesis of shivering. Opioid receptors, α2 receptors, and serotonergic receptors also are involved of shivering.

Various drugs were studied for their potential role in prevention of peri-operative shivering such as tramadol, dexmedetomidine, ondansetron, ketamine, and pethidine.

We decided to perform a well-designed study to compare clonidine and granisetron which has been recently introduced as drugs for prevention and control of shivering after spinal anesthesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

triple blinded

入排标准

年龄范围
21 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient acceptance.,Aged between 21-40 years old, BMI: 18- 30 kg/m2, ASA: I and II., Scheduled for elective cesarean section under spinal anesthesia.

排除标准

  • History of hypersensitivity to drugs used in this study,Patients with history of chronic pain and taking analgesics, Patients with sepsis and Significant cardiac, liver or renal diseases, Uncooperative patients or with psychiatric disorders that prevent surgery under spinal anesthesia, Atrio-ventricular block in any degree, cardiac arrhythmias, valvular heart disease, kidney or liver diseases, neuromuscular disorders and diabetes mellitus

研究组 & 干预措施

Group Cl (clonidine group)

Active Comparator

will be given intravenous Clonidine 0.5 µg/kg diluted in 10ml normal saline 20 minutes before spinal anesthesia

干预措施: Clonidine Injection (Drug)

Group G (granisetron group)

Active Comparator

will be given intravenous 1mg of granisetron 20 minutes before spinal anesthesia.

干预措施: Granisetron Injection (Drug)

Group C (control group)

Placebo Comparator

will be given intravenous10ml normal saline 20 minutes before spinal anesthesia

干预措施: Normal Saline 10 mL Injection (Drug)

结局指标

主要结局

Incidence of Shivering

时间窗: Procedure (through out the period of spinal anesthesia)

• Shivering will be graded according to Tsai and Chu scale (10): 0 = no shivering, 1 = piloerection or peripheral vasoconstriction but no visible shivering, 2 = muscular activity in only one muscle group, 3 = muscular activity in more than one muscle group but not generalized shivering, 4 =shivering involving the whole body

次要结局

  • maternal blood presure(Procedure (preoperative as base and through out the period of spinal anesthesia))
  • baby APGAR score(1 minutes and 5 minutes post natal)
  • core body temperature(Procedure (preoperative as base and through out the period of spinal anesthesia))
  • Maternal Heart rate(Procedure (preoperative as base and through out the period of spinal anesthesia))

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Heba M Fathi

Ass. Professor

Zagazig University

研究点 (1)

Loading locations...

相似试验